Literature DB >> 26375233

Jorge Lobo's disease.

Kalline Andrade de Carvalho1, Marcos César Floriano1, Milvia Maria Simões e Silva Enokihara1, Marta Regina Machado Mascarenhas1.   

Abstract

Jorge Lobo's Disease is a rare, chronic granulomatous cutaneous mycosis, which is typical of tropical and subtropical regions. It is caused by the traumatic implantation of the fungus Lacazia loboi into the skin and subcutaneous tissue. The disease was first described in 1931 by Jorge Lobo, in Recife (PE), Brazil. It is common in Central and South America, and predominates in the Amazon region. We report a case of Jorge Lobo's Disease, which had been initially referred as being paracoccidioidomycosis. We emphasize clinical and diagnostic features of the disease.

Entities:  

Mesh:

Year:  2015        PMID: 26375233      PMCID: PMC4560553          DOI: 10.1590/abd1806-4841.20153603

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


A 47-year-old male patient, who had been living in Macapa (AP) for 10 years presented with a lesion of four years' duration in the right malar region. Physical examination revealed a keloidiform node (Figure 1). Histopathological examination evidenced a granulomatous inflammation with fungal proliferation in the dermis, which was suggestive of Lacazia loboi compatible with Jorge Lobo's disease (Figures 2, 3 and 4).
FIGURE 1

Keloidiform nodes in the malar region of the patient’s face

FIGURE 2

Presence of granulomatous inflammation with intense and diffuse proliferation of fungi in the papillary dermis and superficial reticular dermis, engulfed or not by histiocytes, suggesting Jorge Lobo’s disease - HE 100x

FIGURE 3

Fungi and granulomatous infi ltrate in detail - HE 400x

FIGURE 4

Grocott’s method to show the distribution of fungi in the dermis - 400x

Keloidiform nodes in the malar region of the patient’s face Presence of granulomatous inflammation with intense and diffuse proliferation of fungi in the papillary dermis and superficial reticular dermis, engulfed or not by histiocytes, suggesting Jorge Lobo’s disease - HE 100x Fungi and granulomatous infi ltrate in detail - HE 400x Grocott’s method to show the distribution of fungi in the dermis - 400x Jorge Lobo's Disease is a rare, chronic granulomatous cutaneous infection caused by the traumatic implantation of the fungus Lacazia loboi into the skin and subcutaneous tissue. The disease was first described in 1931 by the dermatologist Jorge Lobo, in Recife (PE), Brazil.[1] It is common in Central and South America, and predominates in the Amazon region.[2,3] There are about 550 cases reported in the literature. Of these, 322 occurred in Brazil. About 90% of cases have occurred in forest workers.[4,5] Clinically, it is characterized by a large polymorphism of cutaneous lesions. Keloidiform nodes usually predominate. It primarily affects exposed areas of the skin, tending to spare mucous membranes. Local symptoms are bloating, itching and pain on palpation. It may affect the lymph nodes, but not internal organs.[6,7] The diagnosis is made based on anatomicopathological evidence and presence of the fungus in the skin lesion; culture is negative. Pathology shows nodular and diffuse granulomatous inflammatory infiltrate in the dermis, consisting of macrophages and numerous multinucleated Langerhans'-type cells and foreign body cells filled wih fungi. Fungus examination shows globoid structures with thick, double-contour walls, which reproduce by simple budding. They are usually rosary-shaped or dumbbell-shaped.[7,8,9] Surgery is the usual conduct of choice for isolated lesions. Some studies have described the use of cryotherapy. There are no effective drugs for disseminated forms of the disease.
  8 in total

1.  Comparative morphology of Lacazia loboi (syn. Loboa loboi) in dolphins and humans.

Authors:  E M Haubold; C R Cooper; J W Wen; M R McGinnis; D F Cowan
Journal:  Med Mycol       Date:  2000-02       Impact factor: 4.076

2.  [Natural history of Jorge Lobo's disease. Occurrence among the Caiabi Indians (Central Brazil)].

Authors:  R G Baruzzi; C da S Lacaz; F A de Souza
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1979 Nov-Dec       Impact factor: 1.846

Review 3.  Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment.

Authors:  Flavio Queiroz-Telles; Marcio Nucci; Arnaldo Lopes Colombo; Angela Tobón; Angela Restrepo
Journal:  Med Mycol       Date:  2010-12-03       Impact factor: 4.076

Review 4.  Lobomycosis.

Authors:  G Rodríguez-Toro
Journal:  Int J Dermatol       Date:  1993-05       Impact factor: 2.736

5.  Lobomycosis successfully treated with posaconazole.

Authors:  Beatriz Bustamante; Carlos Seas; Martín Salomon; Francisco Bravo
Journal:  Am J Trop Med Hyg       Date:  2013-04-01       Impact factor: 2.345

6.  Squamous-cell carcinoma and lobomycosis (Jorge Lobo's disease).

Authors:  R G Baruzzi; D A Rodrigues; N S Michalany; R Salomão
Journal:  Int J Dermatol       Date:  1989-04       Impact factor: 2.736

7.  Lobomycosis: A case from Southeastern Europe and review of the literature.

Authors:  Evangelia Papadavid; Maria Dalamaga; Irini Kapniari; Ekaterini Pantelidaki; Sotirios Papageorgiou; Vassiliki Pappa; Panagiotis Tsirigotis; Ioannis Dervenoulas; Nikolaos Stavrianeas; Dimitrios Rigopoulos
Journal:  J Dermatol Case Rep       Date:  2012-09-28

Review 8.  Lobomycosis: risk of zoonotic transmission from dolphins to humans.

Authors:  John S Reif; Adam M Schaefer; Gregory D Bossart
Journal:  Vector Borne Zoonotic Dis       Date:  2013-08-06       Impact factor: 2.133

  8 in total
  1 in total

1.  Epidemiologic and Clinical Progression of Lobomycosis among Kaiabi Indians, Brazil, 1965-2019.

Authors:  Marcos C Florian; Douglas A Rodrigues; Sofia B M de Mendonça; Arnaldo L Colombo; Jane Tomimori
Journal:  Emerg Infect Dis       Date:  2020-05       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.